Our pathbreaking research
Filter Results:
-
A legendary study of antihypertensive drugs
To identify the best medication for newly diagnosed patients, LEGEND takes a novel tack.
-
A pioneering prostate cancer study
For some patients, no treatment is best. Weighing the risks and benefits of watchful waiting.
-
OHDSI community spurs early COVID-19 studies
In a four-day marathon, 330 volunteers from 30 countries came together to ask and answer questions.